Trials / Completed
CompletedNCT00889070
Respiratory Events Among Premature Infants
Respiratory Events Among Premature Infants (32-<36 w/GA) - Outcomes & Risk Tracking Study (The REPORT Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- MedImmune LLC · Industry
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Not accepted
Summary
Assess the burden of disease associated with RSV infection with premature children in an outpatient setting.
Detailed description
The primary objective of this prospective study is to assess the burden of disease associated with RSV infection, as measured/determined by rates of outpatient medically attended LRI, emergency room visits and hospitalization among preterm infants (32-≤36 wGA) during RSV season, and its medical/health consequences, as measured by wheezing events, the infant's first RSV season, up to May 2009.
Conditions
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2009-04-28
- Last updated
- 2009-08-07
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00889070. Inclusion in this directory is not an endorsement.